2021全球药物结晶高峰论坛发布最新议程

021全球药物结晶高峰论坛发布最新议程"

021全球药物结晶高峰论坛发布最新议程"


 




2021全球药物结晶

高峰论坛发布最新议程


与利兹大学,MIT、明尼苏达大学等领衔结晶教授、辉瑞、默克、BMS、礼来等公司的结晶专家相约金秋10月,通过赋能技术,突破药物开发瓶颈


 …………. 



The Center for Pharma Crystallization (CfPC) at J-Star Research, Inc., a subsidiary of Porton Pharma Solutions, is pleased to announce the program of 2nd annual Pharmaceutical Crystallization Summit, to be held on October 14 and 15, 2021, jointly with our partners XtalPi, BlazeMetrics, and Technobis.   博腾股份子公司J-Star Research的药物结晶中心(CfPC)近日宣布,将于2021年10月14日至15日联合晶泰科技、BlazeMetrics和Technobis举办第二届全球药物结晶高峰论坛。

 

The 2-day event includes 4 sessions, with 12 keynote presentations by leading industrial and academic experts, and 3 topical panel discussions moderated by SMEs from the pharma industry. See topical and speaker details at.   这两天的峰会将采用线上与线下相结合的方式,共有12个主题报告和3个专题讨论,分别由制药行业专家来主持。如需详情,请跳转以下地址:

www.pharmaceuticalcrystallizationsummit.com



021全球药物结晶高峰论坛发布最新议程"


Areas of opportunity identified by Enabling Technologies Consortium (ETC)  赋能技术联盟(ETC)确认的潜在发展领域


Crystal structure prediction 晶体结构预测

Crystal shape prediction 晶体形貌预测

Solubility assessment 溶解度评估

Purification 纯化

Analytical technologies 分析技术




Areas of potential innovation identified by National Academies of Sciences, Engineering, and Medicine (NASEM)

美国国家科学工程医药学院(NASEM)确认的潜在创新领域


Co-processed APIs 协同加工API

Process intensification 过程强化

Additive manufacturing 制剂辅料生产

Advanced process control & automation 先进过程控制与自动化

Modular systems 模块化系统



议程安排

(以下时间均为北京时间


 第一天  


Friday, October 15, 2021  

 2021年10月15日星期五

Session 1: Smarter Solid Form & Pre-formulation Studies  

论坛1:更智能的固态和处方前制剂研究

Moderator: Dr. Shanming Kuang 

主持人:匡善明博士


021全球药物结晶高峰论坛发布最新议程"

Dr. Shanming Kuang

Head of Center for Pharma Crystallizationat Shanghai Branch, Porton Pharma Solutions Senior Director of Solid Form Studies, Center for Pharma Crystallization, J-Star Research Inc.

博腾上海药物结晶中心主任/

J-STAR药物结晶中心固态研发高级总监



021全球药物结晶高峰论坛发布最新议程"

20:15 – 21:05

Dr. Alfred Lee | Principal Scientist

Merck Research Laboratories


Topic 议题

Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264): A Solid-State Chemistry Perspective 

从固态化学角度探讨绿色可持续的Gefapixant枸橼酸(MK-7264)生产工艺的开发

021全球药物结晶高峰论坛发布最新议程"

21:05 – 21:55

Dr. Ann Newman

Solid-State and Pharmaceutical Consultant

Seventh Street Development Group


Topic 议题

What Solid Form Should I Choose?

如何选择固体形态?

021全球药物结晶高峰论坛发布最新议程"

22:15 – 23:05

Dr. Shawn Yin | Research Fellow

Bristol-Myers Squibb


Topic 议题

Understanding and Controlling the API Form/Powder Property Risks in Drug Substance and Product Processes

理解并控制原料药和成品药工艺过程中关于晶型/粉末特性的风险

021全球药物结晶高峰论坛发布最新议程"

23:05 – 23:55

Dr. Jessica Bruhn | Principal Scientist

NanoImaging Services


Chandler Greenwell | Applications Scientist

XtalPi Inc.


Dr. Harsh Shah 

Senior Scientist

J-Star Research


Topic 议题

Absolute Structure Determination of API Molecules by MicroED Analysis of Co-Crystals Formed Based on COSMO-RS Prediction

基于COSMO-RS预测制备共晶并用MicroED分析共晶确定原料药分子的绝对结构


Friday, October 15, 2021  

 2021年10月15日星期五

Session 2: Particle Engineering & DS-DP Co-Processing   

论坛2:粒子工程和原料药-成品药协同加工

Moderator: Dr. San Kiang

主持人:江山博士


021全球药物结晶高峰论坛发布最新议程"

Dr. San Kiang

Chief Technology Officer     

Porton Pharmatech/J-Star Research

重庆博腾药业有限公司/J-STAR

首席技术官




021全球药物结晶高峰论坛发布最新议程"

01:05 – 01:55

Dr. Christopher Burcham

Senior Engineering Research Advisor

Eli Lilly and Company


Topic 议题

Examples of Particle Engineering to Improve Patient Outcomes and Product Manufacturing

通过粒子工程帮助患者改善产品生产的几个案例


021全球药物结晶高峰论坛发布最新议程"

01:55 – 02:45

Prof. Junbo Gong

School of Chemical Engineering and Technology    

Tianjin University


Topic 议题

Crystal habit modifications and spherical crystallization design in solution

溶液中调控晶习和球型结晶设计


021全球药物结晶高峰论坛发布最新议程"

03:05 – 03:55

Prof. Changquan Calvin Sun

Professor, Director of Graduate Studies, and Associate Department Head, Department of Pharmaceutics

University of Minnesota


Topic 议题

Challenges and Opportunities in Optimizing Mechanical Properties of Drugs by Incorporating Excipients

加入辅料优化药物力学性能面临的挑战和机遇


021全球药物结晶高峰论坛发布最新议程"

03:55 – 04:45

Dr. Jian Wang

SVP, Center for Pharma Crystallization, Porton/J-Star


Topic 议题

Bridging the Gap between Drug Substance and Drug Product Productions via Co-Processing

通过原料药与成品药的协同加工来克服药物生产中的瓶颈问题




021全球药物结晶高峰论坛发布最新议程"



 第二天  


Saturday, October 16, 2021  

2021年10月16日,星期六

Session 3: Physical Property Based Crystallization Process Development 

论坛3:基于物理属性的结晶工艺研发

Moderator: Dr. Yuriy Abramov

主持人:Yuriy Abramov博士


021全球药物结晶高峰论坛发布最新议程"


Dr. Yuriy A.Abramov    

VP of Scientific Affairs XtalPi Inc.

Yuriy A.Abramov博士 

晶泰科技/科学事务副总裁




021全球药物结晶高峰论坛发布最新议程"

20:15 – 21:05

Prof. Kevin J Roberts

Brotherton Professor of Chemical Engineering

University of Leeds


Topic 议题

The Importance of Understanding and Characterising the Physical & Chemical Properties of APIs in the Digital Design of Drug Products

理解并表征原料药理化性质对于成品药数字化设计的重要性

021全球药物结晶高峰论坛发布最新议程"

21:05 – 21:55

Prof. Allan Myerson

Professor of the Practice

Massachusetts Institute of Technology


Topic 议题

Continuous Crystallization and Purification:The Role of Impurity Incorporation Mechanism in Non-Equilibrium Processes

连续结晶与纯化:含杂机理对非平衡工艺过程的重要性

021全球药物结晶高峰论坛发布最新议程"

22:15 – 23:05

Dr. Samir Kulkarni

Principal Scientist

Pfizer


Topic议题

Co-Crystals Platform to Improve Physical Properties of Early Intermediates during API Manufacturing Process

改善原料药制备工艺中前步中间体物理性质的共晶平台

021全球药物结晶高峰论坛发布最新议程"

23:05 – 23:55

Prof. Kenneth Morris

University Professor    

Long Island University

Director of the Lachman Institute for Pharmaceutical Analysis


Topic 议题

Correlation of Solubility with the Metastable Limit

溶解度与介稳极限的关联模拟

Saturday, October 16, 2021  

2021年10月16日,星期六

Session 4: Topical Panel Discussions  

论坛4:专题讨论

Moderator: Dr. Alfred Lee  

主持人:Alfred Lee 博士


021全球药物结晶高峰论坛发布最新议程"

Dr. Alfred Lee

Principal Scientist

Merck Research Laboratories

Alfred Lee 博士 默克研究实验室
Principal Scientist




021全球药物结晶高峰论坛发布最新议程"

01:10 – 01:45

Dr. Alfred Lee

Principal Scientist

Merck Research Laboratories


Topic 议题

Potentials and Technologies to Increase Success Rate of Polymorph Screening

提高晶型筛选成功率的潜力和技术

021全球药物结晶高峰论坛发布最新议程"

01:45 – 02:20

Kevin Girard

Associate Research Fellow

Pfizer


Topic 议题 

Overcoming Industrial Challenges in Implementation of Crystallization Technologies

克服实施结晶技术面临的工业问题

021全球药物结晶高峰论坛发布最新议程"

02:20 – 02:55

Dr. Christopher Burcham

Senior Engineering Research Advisor

Eli Lilly and Company


Topic 议题

Realizing   Regulatory Challenges in Applying Crystallization Technologies

克服应用结晶技术面临的监管问题

02:55 – 03:00

Closing Remarks by Chairman, Dr. San Kiang, J-Star Research/Porton 

大会主席致闭幕词

San Kiang 博士

博腾/J-STAR




021全球药物结晶高峰论坛发布最新议程"


 …………. 



“Serving the patients with the right DP (drug product) in the fastest way possible requires scientists on the API (active pharmaceutical ingredient) side, and DP side to work hand in hand, not in isolation. The speakers at this conference will demonstrate how this kind of collaboration can lead to experimental and theoretical tools to better understand the fundamentals of APIs, their interaction with excipients, API crystallization and formulation processes.” stated by Dr. San Kiang, CTO of Porton, Chairman of the Pharmaceutical Crystallization Summit.


“为了尽快给患者研发出好的成品药,原料药科学家和成品药科学家应打破孤立携手合作。本次峰会的演讲嘉宾们会有力地说明,如何通过携手合作,融合实践经验和理论技术的边际,来帮助理解原料药的基本原理、原料药与辅料的相互作用以及原料药结晶和配方工艺。” 

——本届药物结晶高峰论坛主席、博腾药业CTO江山博士。


“I’m really excited about this year’s Summit. The superb program that is in place will offer in-depth scientific and technical discussions on crystallization technologies, geared towards overcoming hurdles in new drug development programs,” said by Dr. Jian Wang, SVP, CfPC at J-Star Research. “I look forward to meeting both old and new friends in the pharma crystallization field in October.”


“对于今年的峰会,我真的很兴奋。已经准备好的峰会内容将给参会者们提供关于结晶技术的深入科学技术性讨论,旨在攻克新药开发中的难题。我十分期待10月份与药物结晶领域的新老朋友相会。”

——博腾/JSTAR 高级副总裁王建博士。




 …………. 



Please contact cfpc@jstar-research.com for any question you may have. We look forward to seeing you at the Summit.

如有疑问,请联系 cfpc@jstar-research.com。

我们期待在峰会相见。


Warmly welcome our friends to follow us on this Summit in the coming months.

热烈欢迎大家持续关注。






021全球药物结晶高峰论坛发布最新议程"
END
021全球药物结晶高峰论坛发布最新议程"


021全球药物结晶高峰论坛发布最新议程"

021全球药物结晶高峰论坛发布最新议程"

021全球药物结晶高峰论坛发布最新议程"点击这里,了解更多博腾股份!

本篇文章来源于微信公众号:药时代

发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权

分享本页
返回顶部